MIBI
CMR Product code: С007
MIBI is the sterile non-radioactive lyophilizate that is intended for use after the labelling with Technetium-99m. Radiopharmaceuticals are prepared directly before it use in the clinics and medical centers.
Trade name: Technetril, 99mTc
INN: Sestamibi
Cold Kit content:
Stannous dichloride – 0,05 mg/vial
Copper tetramibi tetrafluoroborate – 0,80 mg/vial
L-cysteine hydrochloride monohydrate – 1,2 mg/vial
Mannitol – 10,0 mg/vial
Sodium dihydrogencitrate – 11,0 mg/vial
Radiopharmaceutical activity (99mTc): 37 – 1850 MBq/vial
Designation:
is suitable agent for estimation the myocardial perfusion in various pathological processes that lead to the disorder of the blood supply (coronary atherosclerosis, acute myocardial infarction, post-infarction and post myocarditis cardiosclerosis, coronary heart disease), as well as to visualize the malignant tumors of lungs and breast.
Cold kit expiry: 12 months after the production date.
Radiopharmaceutical expiry: 5 hours since the preparation.
MIBI is the sterile non-radioactive lyophilizate that is intended for use after the labelling with Technetium-99m. Radiopharmaceuticals are prepared directly before it use in the clinics and medical centers.
Trade name: Technetril, 99mTc
INN: Sestamibi
Cold Kit content:
Stannous dichloride – 0,05 mg/vial
Copper tetramibi tetrafluoroborate – 0,80 mg/vial
L-cysteine hydrochloride monohydrate – 1,2 mg/vial
Mannitol – 10,0 mg/vial
Sodium dihydrogencitrate – 11,0 mg/vial
Radiopharmaceutical activity (99mTc): 37 – 1850 MBq/vial
Designation:
is suitable agent for estimation the myocardial perfusion in various pathological processes that lead to the disorder of the blood supply (coronary atherosclerosis, acute myocardial infarction, post-infarction and post myocarditis cardiosclerosis, coronary heart disease), as well as to visualize the malignant tumors of lungs and breast.
Cold kit expiry: 12 months after the production date.
Radiopharmaceutical expiry: 5 hours since the preparation.
Other products
Click to order
